← Back to news

Markets

Barclays Is Bullish on UiPath, Inc. (PATH) Amid Stable IT Spending Outlook

Y

Analysts Highlight Chord Energy Corporation (CHRD)’s Disciplined Approach to Capital and Shareholder Returns

Y

Wells Fargo Is Bullish on Inspire Medical Systems, Inc. (INSP) Despite Short-Term Reimbursement Concerns

Y

Thailand Targets Early 2026 for Crypto ETF Regulations

Y

Jim Cramer Explains Why He Thinks NVIDIA’s Jensen Huang Is the “Greatest Technologist of Our Era”

Y

Jim Cramer on Micron CEO: “Sanjay’s Always Preferred Building in America, and That’s One of the Reasons Why I Salute Him”

Y

Jim Cramer on Constellation Energy: “The Fact Is That When the President Gets Involved, It’s Too Uncertain”

Y

Jim Cramer Says He “Would Be a Buyer of STMicro”

Y

Jim Cramer Says Medline “Stock Is Unbelievable” And Recommends Buying It

Y

Jim Cramer on Smith & Nephew: “This Group, I Do Not Like”

Y

Jim Cramer on UiPath: “You Might Have to Wait a Little Bit Longer, But I Think the Upside Is What Beckons There”

Y

Jim Cramer on Huntington Bancshares: “They’re Terrific”

Y

Jim Cramer on Alkermes: “I Think It’s a Hold, Maybe a Weak One”

Y

Jim Cramer on Super Micro: “Sell, I Don’t Need That”

Y

Jim Cramer Shows Bullish Sentiment Toward Oscar Health Because of CEO Mark Bertolini

Y

Jim Cramer on Ares Capital: “I Want to Be Very Careful There”

Y

Jim Cramer on Honeywell: “It’s Finally Getting Credit for All the Things It’s Doing”

Y

Jim Cramer on Simon Property’s CEO: “We Think David Simon’s the Best Mall Operator There Is”

Y

Jim Cramer on Crinetics: “That’s a Better Spec Than Aquestive”

Y

Jim Cramer on GE HealthCare: “I Just Don’t Think It’s What You Want to Own”

Y

Jim Cramer Says “Let’s Buy CVS, Not UnitedHealth”

Y

Jim Cramer on Aquestive Therapeutics: “I’m Not Sure If They Deserve the Benefit of the Doubt”

Y

Jim Cramer on FedEx Freight Spin-Off Plans: “This Deserves a Lot of Attention”

Y

Jim Cramer Says “When the Freight Market Turns Around, J.B.Hunt Should Be Able to Make a Fortune”

Y

Jim Cramer on Boeing: “It’s My Favorite Stock in the Charitable Trust”

Y

Jim Cramer Calls Lam Research the “Best of the Best” But Warns Against Buying Parabolic Moves

Y

8 Undervalued Tech Stocks That Could Rip Higher After Q4 Results

I

What Investors Should Know Before Buying Incyte

S

Where And Why For Gold And Silver

S

Is It Too Late for a Roth Conversion? I'm 60 With $930k in My IRA and Have Started Social Security.

Y

Micron Technology: Structural Demand Is Replacing Cyclical Volatility

S

Oklo: Meta Just Turned A Maybe Into A When

S

Ares Capital: A Quality Cash Cow With A 9.3% Yield

S

Australia watchdog orders audit of fintech Airwallex on suspected compliance miss

Y

Housing Market’s Blue Christmas: Pending Sales Slide Most Since 2001

Y

CFP Board Taps K. Dane Snowden as Next CEO

Y

Fanuc Corporation ADR (FANUY) Shares Gain After Earnings Beat and Guidance Upgrade

Y

US stocks climb some more after Trump calls off his tariffs for Greenland

Y

JPMorgan Resumes Coverage of Chevron (CVX) with ‘Overweight’ Rating

Y

ConocoPhillips (COP) Downgraded at JPMorgan

Y

EOG Resources (EOG) Price Target Lowered by $7

Y

HF Sinclair (DINO) Price Target Reduced by $1, ‘Overweight’ Rating Maintained

Y

Exxon Mobil (XOM) Price Target Raised by $9 at JPMorgan

Y

Ovintiv (OVV) Price Target Raised to $54

Y

Analyst Raises Price Target on Phillips 66 (PSX)

Y

Chord Energy (CHRD) Price Target Reduced by $6

Y

Shell Expects Uptick in Upstream Production in Q4 2025

Y

BP Expects Strong Reduction in Net Debt in Q4 2025

Y

Canadian Natural Resources (CNQ) in Talks to Acquire Natural Gas Properties from Tourmaline

Y

Scotiabank Raises CVX Target to $168 in U.S. Integrated Oil and E&P Update

Y